Mirae Asset Global ETFs Holdings
AKTS icon

Mirae Asset Global ETFs Holdings’s Aktis Oncology AKTS Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio AKTS Stock Details AKTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$315K Buy
9,769
+118
+1% +$2.42K ﹤0.01% 2263
2026
Q1 		$173K Buy
+9,651
New +$187K ﹤0.01% 2432

Other funds holding AKTS

MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $665M AUM 95.48% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
RTW Investments
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
RA Capital Management
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Jupiter Topco
Jupiter Topco New York $245B AUM
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Mirae Asset Global ETFs Holdings's AKTS Position: Q2 2026 in Review

Mirae Asset Global ETFs Holdings increased its Aktis Oncology (AKTS) stake by 1.2% in Q2 2026, buying an estimated $2.42K and bringing the position to 9,769 shares worth $315K. The position accounts for ﹤0.01% of the portfolio, ranked #2263.

Mirae Asset Global ETFs Holdings first reported a position in AKTS in Q1 2026 and has held it in 2 quarters since. 113 funds tracked by Wall St. Rank hold AKTS as of Q2 2026.

  • Mirae Asset Global ETFs Holdings held 9,769 shares of Aktis Oncology worth $315K as of Q2 2026.
  • Mirae Asset Global ETFs Holdings bought 118 Aktis Oncology shares in Q2 2026, an estimated $2.42K.
  • Aktis Oncology made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q2 2026, its #2263 holding.
  • Mirae Asset Global ETFs Holdings first reported a position in Aktis Oncology in Q1 2026 and has held it in 2 quarters since.
  • 113 funds tracked by Wall St. Rank held Aktis Oncology as of Q2 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.